Kymera Therapeutics (KYMR) Stock Research

Kymera Therapeutics

· KYMR

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

9.189 B

+1.16%

Monday

Kymera Therapeutics placed on 'Positive Catalyst Watch' at JPMorgan

KYMR

Sep 28, 7:31 AM

Thursday

Kymera Therapeutics resumed with Early-Stage Biotech at Goldman Sachs

KYMR

Sep 24, 4:49 AM

Over a week ago

Kymera Therapeutics price target raised by $20 at Stifel, here's why

KYMR

Sep 22, 6:21 AM

Kymera Therapeutics management to meet with Piper Sandler

KYMR

Sep 15, 4:48 PM

Kymera Therapeutics price target raised by $21 at BofA, here's why

KYMR

Sep 14, 8:11 AM

Wolfe upgrades Kymera Therapeutics to Outperform on potential upside

KYMR

Sep 10, 10:22 AM

Wolfe Research gets more bullish on Kymera Therapeutics, upgrades shares

KYMR

Sep 10, 5:39 AM

Kymera Therapeutics price target raised by $35 at Guggenheim, here's why

KYMR

Aug 31, 7:16 AM

Kymera Therapeutics price target raised by $16 at Morgan Stanley, here's why

KYMR

Aug 6, 12:13 PM

Kymera Therapeutics price target raised by $15 at Citi, here's why

KYMR

Aug 6, 6:16 AM

Kymera Therapeutics price target raised by $6 at Barclays

KYMR

Aug 6, 5:34 AM

Kymera Therapeutics reports Q2 EPS (62c), consensus (74c)

KYMR

Aug 5, 7:44 AM

Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls

+11

Jul 30, 9:38 AM

Kymera Therapeutics initiated with neutral view at Deutsche Bank, here's why

KYMR

Jul 30, 4:19 AM

Kymera Therapeutics price target raised by $10 at Guggenheim, here's why

KYMR

Jul 28, 6:38 AM

Kymera Therapeutics CMO Jared Gollob to retire, Terence Rooney to succeed

KYMR

Jul 27, 4:02 PM

Kymera Therapeutics price target raised by $20 at Mizuho, here's why

KYMR

Jul 16, 6:48 AM

American Express, Biogen upgraded: Wall Street's top analyst calls

+12

Jul 13, 9:41 AM

Kymera Therapeutics just downgraded at RBC Capital, here's why

KYMR

Jul 13, 6:34 AM

Kymera Therapeutics price target raised by $15 at BofA, here's why

KYMR

Jun 30, 7:52 AM

Kymera Therapeutics price target raised by $38 at B. Riley, here's why

KYMR

Jun 29, 8:32 AM

Kymera Therapeutics price target raised by $20 at Truist, here's why

KYMR

Jun 29, 7:22 AM

Kymera Therapeutics price target raised by $23 at Canaccord, here's why

KYMR

Jun 26, 7:55 AM

What You Missed On Wall Street On Thursday

+23

Jun 25, 4:11 PM

Charts